中国癌症防治杂志Issue(6)：403-406,407,5.DOI:10.3969/j.issn.1674-5671.2015.06.04
2003~2013年某肿瘤专科医院肝细胞癌肿瘤分期及首次治疗方法调查分析
Tumor stage and primary treatment selection among patients with hepatocellular carcinoma from 2003 to 2013
摘要
Abstract
Objective This study reviewed the frequencies of each tumor stage and each type of primary treatment modality among patients with primary hepatocellular carcinoma (HCC)treated at a tertiary tumor hospital over the last decade . Methods Baseline data of patients with primary HCC treated between January 2003 and October 2013 were retrospectively collected. Tumor stage was determined according to the Barcelona Clinic Liver Cancer (BCLC) staging system. Results A total of 6 ,241 patients with primary HCC were included in the analysis ,of whom 28 . 9% were in stage BCLC-0/A;16 . 2% ,BCLC-B;53 . 6% ,BCLC-C;and 1 . 3% ,BCLC-D . Treatment modalities applied to this patient group were as follows:hepatic resection,33.3%;interventional therapy,36.7%;radiotherapy,2.2%;ablation therapy,0.9%;systemic chemotherapy ,8 . 8%;traditional herbal medicine therapy ,4 . 2%;targeted drug therapy ,0 . 1%;and no treatment , 13 . 8%. Hepatic resection was the most frequent therapy for patients with BCLC-0/A/B disease , and interventional treatment was the first-line therapy for patients with BCLC-C disease . Conclusion Prevalence of stage BCLC-B and-C disease was high among our HCC patients . Hepatic resection and interventional treatment are first-line therapies for both stages .关键词
肝肿瘤/巴塞罗那临床肝癌分期系统/治疗方法/调查分析Key words
Liver neoplasm/Barcelona Clinic liver cancer/Treatment/Survey and analysis分类
医药卫生引用本文复制引用
钟鉴宏,游雪梅,马良,向邦德,吴飞翔,彭宁福,龚文锋,黎乐群..2003~2013年某肿瘤专科医院肝细胞癌肿瘤分期及首次治疗方法调查分析[J].中国癌症防治杂志,2015,(6):403-406,407,5.基金项目
国家科技重大专项课题（2012ZX10002010001009）；广西卫生厅自筹经费科研课题 （）
